+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacovigilance Market Research Report by Clinical Trial, by Method, by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5306611
  • Report
  • March 2021
  • Region: Global
  • 186 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
1 of 4
The Global Pharmacovigilance Market to Grow USD 9,530.87 Million by 2025, at a CAGR of 10.83%

FEATURED COMPANIES

  • Accenture, PLC
  • Covance Inc.
  • HCL Technologies
  • IQVIA
  • Oracle Corporation
  • Syneos Health
  • MORE
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Pharmacovigilance Market is expected to grow from USD 5,698.23 Million in 2020 to USD 9,530.87 Million by the end of 2025.
2. The Global Pharmacovigilance Market is expected to grow from EUR 4,996.31 Million in 2020 to EUR 8,356.84 Million by the end of 2025.
3. The Global Pharmacovigilance Market is expected to grow from GBP 4,441.73 Million in 2020 to GBP 7,429.25 Million by the end of 2025.
4. The Global Pharmacovigilance Market is expected to grow from JPY 608,145.53 Million in 2020 to JPY 1,017,185.34 Million by the end of 2025.
5. The Global Pharmacovigilance Market is expected to grow from AUD 8,274.58 Million in 2020 to AUD 13,840.09 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Clinical Trial, the Pharmacovigilance Market is examined across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
  • Based on Method, the Pharmacovigilance Market is examined across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.
  • Based on Type, the Pharmacovigilance Market is examined across Contract Outsourcing and In-house.
  • Based on End User, the Pharmacovigilance Market is examined across Academic & Research Institutes, Government Agencies, Health Insurance Companies, and Hospitals & Care Providers.
  • Based on Geography, the Pharmacovigilance Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmacovigilance Market including Accenture, PLC, Bristol-Myers Squibb, C.H. Boehringer Sohn AG & Ko. KG, Capgemini SE, Clinquest Group B.V., Covance Inc., F. Hoffmann-La Roche AG, FMD K&L Inc, GlaxoSmithKline PLC, HCL Technologies, IBM Corporation, ICON PLC, Infosys Limited, IQVIA, ITclinical, Janssen Research & Development, LLC, Laboratory Corporation, Laboratory Corporation of America Holdings, Novartis International AG, Oracle Corporation, PAREXEL International, Pfizer Inc., Quanticate International limited, Sanofi S.A., Syneos Health, Take Solutions Ltd., Tata Consultancy Services, and Wipro Limited.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmacovigilance Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmacovigilance Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacovigilance Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacovigilance Market?
4. What is the competitive strategic window for opportunities in the Global Pharmacovigilance Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmacovigilance Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pharmacovigilance Market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Accenture, PLC
  • Covance Inc.
  • HCL Technologies
  • IQVIA
  • Oracle Corporation
  • Syneos Health
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Method Outlook
3.5. Clinical Trial Outlook
3.6. End User Outlook
3.7. Geography Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of chronic diseases
5.1.1.2. Rise in pharmacovigilance application in spontaneous reporting and electronic health record (EHR) mining
5.1.1.3. Rise in demand for outsourcing services by players
5.1.1.4. Rising incidence of ADR and drug toxicity
5.1.2. Restraints
5.1.2.1. High-cost technology for small and mid-sized player
5.1.3. Opportunities
5.1.3.1. Emergence of COVDI-19 have opened new opportunities
5.1.3.2. Rising investment in R&D by healthcare companies
5.1.4. Challenges
5.1.4.1. Lack of skilled labor
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Pharmacovigilance Market, By Clinical Trial
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV
6.6. Pre-clinical

7. Global Pharmacovigilance Market, By Method
7.1. Introduction
7.2. Cohort Event Monitoring
7.3. EHR Mining
7.4. Intensified ADR Reporting
7.5. Spontaneous Reporting
7.6. Targeted Spontaneous Reporting

8. Global Pharmacovigilance Market, By Type
8.1. Introduction
8.2. Contract Outsourcing
8.3. In-house

9. Global Pharmacovigilance Market, By End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Government Agencies
9.4. Health Insurance Companies
9.5. Hospitals & Care Providers

10. Americas Pharmacovigilance Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pharmacovigilance Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Pharmacovigilance Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Accenture, PLC
14.2. Bristol-Myers Squibb
14.3. C.H. Boehringer Sohn AG & Ko. KG
14.4. Capgemini SE
14.5. Clinquest Group B.V.
14.6. Covance Inc.
14.7. F. Hoffmann-La Roche AG
14.8. FMD K&L Inc
14.9. GlaxoSmithKline PLC
14.10. HCL Technologies
14.11. IBM Corporation
14.12. ICON PLC
14.13. Infosys Limited
14.14. IQVIA
14.15. ITclinical
14.16. Janssen Research & Development, LLC
14.17. Laboratory Corporation
14.18. Laboratory Corporation of America Holdings
14.19. Novartis International AG
14.20. Oracle Corporation
14.21. PAREXEL International
14.22. Pfizer Inc.
14.23. Quanticate International limited
14.24. Sanofi S.A.
14.25. Syneos Health
14.26. Take Solutions Ltd.
14.27. Tata Consultancy Services
14.28. Wipro Limited

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
Figure 1. Global Pharmacovigilance Market: Research Process
Figure 2. Global Pharmacovigilance Market: Research Execution
Figure 3. Global Pharmacovigilance Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Pharmacovigilance Market Size, by Type, 2020 (USD Million)
Figure 5. Global Pharmacovigilance Market Size, by Method, 2020 (USD Million)
Figure 6. Global Pharmacovigilance Market Size, by Clinical Trial, 2020 (USD Million)
Figure 7. Global Pharmacovigilance Market Size, by End-user, 2020 (USD Million)
Figure 8. Global Pharmacovigilance Market Size, by Geography, 2020 (USD Million)
Figure 9. Global Pharmacovigilance Market Size, 2018-2025 (USD Million)
Figure 10. Global Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (%)
Figure 11. Global Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 12. Competitive Strategic Window for Global Pharmacovigilance Market Size, by Geography, 2025
Figure 13. Global Pharmacovigilance Market: Market Dynamics
Figure 14. Global Pharmacovigilance Market: Porters Five Forces Analysis
Figure 15. Global Pharmacovigilance Market Size, by Clinical Trial, 2020 Vs 2025 (%)
Figure 16. Global Pharmacovigilance Market Size, by Clinical Trial, 2020 Vs 2025 (USD Million)
Figure 17. Competitive Strategic Window for Global Pharmacovigilance Market Size, by Clinical Trial, 2025
Figure 18. Global Pharmacovigilance Market Size, by Phase I, 2020 Vs 2025 (USD Million)
Figure 19. Global Pharmacovigilance Market Size, by Phase Ii, 2020 Vs 2025 (USD Million)
Figure 20. Global Pharmacovigilance Market Size, by Phase Iii, 2020 Vs 2025 (USD Million)
Figure 21. Global Pharmacovigilance Market Size, by Phase Iv, 2020 Vs 2025 (USD Million)
Figure 22. Global Pharmacovigilance Market Size, by Pre-Clinical, 2020 Vs 2025 (USD Million)
Figure 23. Global Pharmacovigilance Market Size, by Method, 2020 Vs 2025 (%)
Figure 24. Global Pharmacovigilance Market Size, by Method, 2020 Vs 2025 (USD Million)
Figure 25. Competitive Strategic Window for Global Pharmacovigilance Market Size, by Method, 2025
Figure 26. Global Pharmacovigilance Market Size, by Cohort Event Monitoring, 2020 Vs 2025 (USD Million)
Figure 27. Global Pharmacovigilance Market Size, by Ehr Mining, 2020 Vs 2025 (USD Million)
Figure 28. Global Pharmacovigilance Market Size, by Intensified Adr Reporting, 2020 Vs 2025 (USD Million)
Figure 29. Global Pharmacovigilance Market Size, by Spontaneous Reporting, 2020 Vs 2025 (USD Million)
Figure 30. Global Pharmacovigilance Market Size, by Targeted Spontaneous Reporting, 2020 Vs 2025 (USD Million)
Figure 31. Global Pharmacovigilance Market Size, by Type, 2020 Vs 2025 (%)
Figure 32. Global Pharmacovigilance Market Size, by Type, 2020 Vs 2025 (USD Million)
Figure 33. Competitive Strategic Window for Global Pharmacovigilance Market Size, by Type, 2025
Figure 34. Global Pharmacovigilance Market Size, by Contract Outsourcing, 2020 Vs 2025 (USD Million)
Figure 35. Global Pharmacovigilance Market Size, by In-House, 2020 Vs 2025 (USD Million)
Figure 36. Global Pharmacovigilance Market Size, by End-user, 2020 Vs 2025 (%)
Figure 37. Global Pharmacovigilance Market Size, by End-user, 2020 Vs 2025 (USD Million)
Figure 38. Competitive Strategic Window for Global Pharmacovigilance Market Size, by End-user, 2025
Figure 39. Global Pharmacovigilance Market Size, by Academic & Research Institutes, 2020 Vs 2025 (USD Million)
Figure 40. Global Pharmacovigilance Market Size, by Government Agencies, 2020 Vs 2025 (USD Million)
Figure 41. Global Pharmacovigilance Market Size, by Health Insurance Companies, 2020 Vs 2025 (USD Million)
Figure 42. Global Pharmacovigilance Market Size, by Hospitals & Care Providers, 2020 Vs 2025 (USD Million)
Figure 43. Americas Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (%)
Figure 44. Americas Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 45. Competitive Strategic Window for Americas Pharmacovigilance Market Size, by Geography, 2025
Figure 46. Argentina Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. Brazil Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Canada Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Mexico Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. United States Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Asia-Pacific Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (%)
Figure 52. Asia-Pacific Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 53. Competitive Strategic Window for Asia-Pacific Pharmacovigilance Market Size, by Geography, 2025
Figure 54. Australia Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. China Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. India Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Indonesia Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Japan Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Malaysia Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Philippines Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. South Korea Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Thailand Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Europe, Middle East & Africa Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (%)
Figure 64. Europe, Middle East & Africa Pharmacovigilance Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 65. Competitive Strategic Window for Europe, Middle East & Africa Pharmacovigilance Market Size, by Geography, 2025
Figure 66. France Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. Germany Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Italy Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 69. Netherlands Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 70. Qatar Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 71. Russia Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 72. Saudi Arabia Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 73. South Africa Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 74. Spain Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 75. United Arab Emirates Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 76. United Kingdom Pharmacovigilance Market Size, by Geography, 2018-2025 (USD Million)
Figure 77. Global Pharmacovigilance Market: Fpnv Positioning Matrix
Figure 78. Global Pharmacovigilance Market: Market Share Analysis
Figure 79. Global Pharmacovigilance Market: Competitor SWOT Analysis
Figure 80. Competitive Scenario Analysis in Global Pharmacovigilance Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Pharmacovigilance Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Pharmacovigilance Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Pharmacovigilance Market Size, by Phase I, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Pharmacovigilance Market Size, by Phase Ii, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Pharmacovigilance Market Size, by Phase Iii, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Pharmacovigilance Market Size, by Phase Iv, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Pharmacovigilance Market Size, by Pre-Clinical, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Global Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Global Pharmacovigilance Market Size, by Cohort Event Monitoring, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Global Pharmacovigilance Market Size, by Ehr Mining, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Global Pharmacovigilance Market Size, by Intensified Adr Reporting, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Global Pharmacovigilance Market Size, by Spontaneous Reporting, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Global Pharmacovigilance Market Size, by Targeted Spontaneous Reporting, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Global Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Global Pharmacovigilance Market Size, by Contract Outsourcing, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Global Pharmacovigilance Market Size, by In-House, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Global Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Global Pharmacovigilance Market Size, by Academic & Research Institutes, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. Global Pharmacovigilance Market Size, by Government Agencies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. Global Pharmacovigilance Market Size, by Health Insurance Companies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Global Pharmacovigilance Market Size, by Hospitals & Care Providers, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. Americas Pharmacovigilance Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. Americas Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Americas Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Americas Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. Americas Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. Argentina Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. Argentina Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. Argentina Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. Argentina Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. Brazil Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. Brazil Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. Brazil Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. Brazil Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. Canada Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. Canada Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. Canada Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. Canada Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. Mexico Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. Mexico Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. Mexico Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. Mexico Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. United States Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. United States Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. United States Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. United States Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. Asia-Pacific Pharmacovigilance Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. Asia-Pacific Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. Asia-Pacific Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. Asia-Pacific Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. Asia-Pacific Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Australia Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Australia Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Australia Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. Australia Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. China Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. China Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. China Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. China Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. India Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. India Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. India Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. India Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. Indonesia Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. Indonesia Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. Indonesia Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. Indonesia Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 70. Japan Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 71. Japan Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 72. Japan Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 73. Japan Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 74. Malaysia Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 75. Malaysia Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 76. Malaysia Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 77. Malaysia Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 78. Philippines Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 79. Philippines Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 80. Philippines Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 81. Philippines Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 82. South Korea Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 83. South Korea Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 84. South Korea Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 85. South Korea Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 86. Thailand Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 87. Thailand Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 88. Thailand Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 89. Thailand Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 90. Europe, Middle East & Africa Pharmacovigilance Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 91. Europe, Middle East & Africa Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 92. Europe, Middle East & Africa Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 93. Europe, Middle East & Africa Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 94. Europe, Middle East & Africa Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 95. France Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 96. France Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 97. France Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 98. France Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 99. Germany Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 100. Germany Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 101. Germany Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 102. Germany Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 103. Italy Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 104. Italy Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 105. Italy Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 106. Italy Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 107. Netherlands Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 108. Netherlands Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 109. Netherlands Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 110. Netherlands Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 111. Qatar Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 112. Qatar Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 113. Qatar Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 114. Qatar Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 115. Russia Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 116. Russia Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 117. Russia Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 118. Russia Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 119. Saudi Arabia Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 120. Saudi Arabia Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 121. Saudi Arabia Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 122. Saudi Arabia Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 123. South Africa Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 124. South Africa Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 125. South Africa Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 126. South Africa Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 127. Spain Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 128. Spain Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 129. Spain Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 130. Spain Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 131. United Arab Emirates Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 132. United Arab Emirates Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 133. United Arab Emirates Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 134. United Arab Emirates Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 135. United Kingdom Pharmacovigilance Market Size, by Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 136. United Kingdom Pharmacovigilance Market Size, by Method, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 137. United Kingdom Pharmacovigilance Market Size, by Clinical Trial, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 138. United Kingdom Pharmacovigilance Market Size, by End-user, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 139. Global Pharmacovigilance Market: Scores
Table 140. Global Pharmacovigilance Market: Business Strategy
Table 141. Global Pharmacovigilance Market: Product Satisfaction
Table 142. Global Pharmacovigilance Market: Ranking
Table 143. Global Pharmacovigilance Market: Merger & Acquisition
Table 144. Global Pharmacovigilance Market: Agreement, Collaboration, & Partnership
Table 145. Global Pharmacovigilance Market: New Product Launch & Enhancement
Table 146. Global Pharmacovigilance Market: Investment & Funding
Table 147. Global Pharmacovigilance Market: Award, Recognition, & Expansion
Table 148. Global Pharmacovigilance Market: License & Pricing
Note: Product cover images may vary from those shown
3 of 4
  • Accenture, PLC
  • Bristol-Myers Squibb
  • C.H. Boehringer Sohn AG & Ko. KG
  • Capgemini SE
  • Clinquest Group B.V.
  • Covance Inc.
  • F. Hoffmann-La Roche AG
  • FMD K&L Inc
  • GlaxoSmithKline PLC
  • HCL Technologies
  • IBM Corporation
  • ICON PLC
  • Infosys Limited
  • IQVIA
  • ITclinical
  • Janssen Research & Development, LLC
  • Laboratory Corporation
  • Laboratory Corporation of America Holdings
  • Novartis International AG
  • Oracle Corporation
  • PAREXEL International
  • Pfizer Inc.
  • Quanticate International limited
  • Sanofi S.A.
  • Syneos Health
  • Take Solutions Ltd.
  • Tata Consultancy Services
  • Wipro Limited
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll